Stock comparison
Haemonetics
UnitedHealth
Scored across Buffett, Graham, Lynch and Greenblatt - plus a side-by-side metric table covering valuation, quality, growth and balance sheet.
HAE
Haemonetics
Market cap
$2.88B
Sector
Healthcare
UNH
UnitedHealth
Market cap
$348.42B
Sector
Healthcare
Overall winner
Haemonetics HAE
Wins on the combined sum of fit scores across all four strategies. Per-strategy breakdown below.
Fit scores by strategy
| Strategy | HAE | UNH | Winner |
|---|---|---|---|
| Warren Buffett | 70B | 44D | HAE |
| Benjamin Graham | 85A | 67B | HAE |
| Philip Fisher | 60C | 29F | HAE |
| Peter Lynch | 54C | 23F | HAE |
| Joel Greenblatt | 31F | 37D | UNH |
| Charlie Munger | 54D | 36D | HAE |
| Terry Smith | 55D | 39D | HAE |
Side-by-side metrics
| Metric | HAE | UNH |
|---|---|---|
| Market cap | $2.88B | $348.42B |
| P/E (TTM) | 24.8x | 29.0x |
| EV/EBIT | 14.1x | 21.0x |
| ROIC (TTM) | 8.37% | 8.09% |
| Gross margin | 55.74% | 18.8% |
| Net margin | 7.29% | 2.68% |
| Revenue CAGR 5y | 7.65% | 11.69% |
| EPS CAGR 5y | 24.62% | -7.83% |
| Debt / Equity | 1.5x | 0.7x |
| Dividend yield | 0.0% | 2.3% |
Where each one wins
The metrics with the biggest gap between the two - sorted so the most decisive edges read first.
HAE leads on
- EPS CAGR 5y24.62%vs -7.83%+132%
- Gross margin55.74%vs 18.8%+66%
- Net margin7.29%vs 2.68%+63%
- EV/EBIT14.1xvs 21.0x+33%
UNH leads on
- Dividend yield2.3%vs 0.0%+100%
- Market cap$348.42Bvs $2.88B+99%
- Debt / Equity0.7xvs 1.5x+51%
- Revenue CAGR 5y11.69%vs 7.65%+35%
Related on invest-like
Key terms in this analysis
Educational tool. Fit scores are deterministic projections from public financials onto each investor's published criteria - not personal recommendations or advice.